The present invention relates to means for protecting bioactive materials in mammalian food or feed formulations used to enhance the health status of mammals.

The present invention relates to means for protecting bioactive materials in mammalian food or feed formulations used to enhance the health status of mammals.

The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.

The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.

The present invention relates to a pharmaceutical composition, containing 27-hydroxycholesterol, for preventing or treating myeloid leukemia, and more specifically, to a pharmaceutical composition which suppresses the proliferation of hematopoietic stem cells by increasing the active oxygen of the hematopoietic stem cells and activating a cascade of endoplasmic reticulum stress, and promotes the apoptosis of blood cancer cells by activating the IRE1a, eIF2a, and CHOP signaling pathways which are important for the apoptosis of blood cancer cells.

The present invention relates to a pharmaceutical composition, containing 27-hydroxycholesterol, for preventing or treating myeloid leukemia, and more specifically, to a pharmaceutical composition which suppresses the proliferation of hematopoietic stem cells by increasing the active oxygen of the hematopoietic stem cells and activating a cascade of endoplasmic reticulum stress, and promotes the apoptosis of blood cancer cells by activating the IRE1a, eIF2a, and CHOP signaling pathways which are important for the apoptosis of blood cancer cells.

The present invention relates to means for protecting bioactive materials in mammalian food or feed formulations used to enhance the health status of mammals.

The present invention relates to means for protecting bioactive materials in mammalian food or feed formulations used to enhance the health status of mammals.

The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides, such that the nucleic acid is operably linked to a heteroloqous control sequence for expression. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides set forth in SEQ ID NO:2 and fragments of SEQ ID NO:2.

The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides, such that the nucleic acid is operably linked to a heteroloqous control sequence for expression. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides set forth in SEQ ID NO:2 and fragments of SEQ ID NO:2.